Literature DB >> 20978368

Apoptosis to autophagy switch triggered by the MHC class III-encoded receptor for advanced glycation endproducts (RAGE).

Rui Kang1, Daolin Tang, Michael T Loze, Herbert J Zeh.   

Abstract

The receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin gene superfamily, encoded within the major histocompatability complex class III region. Its multiple ligands include the high mobility group box 1 chromatin binding protein, HMGB1. Recently we reported that RAGE-HMGB1 critically regulates autophagy and apoptosis in pancreatic cancer cells in vivo and in vitro in response to chemotherapy. RAGE inhibits apoptosis ("programmed cell death") by a p53 transcription-independent pathway during the response to chemotherapeutic agents. RAGE sustains autophagy ("programmed cell survival") associated with decreased phosphorylation of the mammalian target of rapamycin (mTOR) and increased Beclin 1-Vps34 interaction. These findings provide insight into how autophagy- and apoptosis-crossregulatory molecules interact in response to cellular stress including tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20978368     DOI: 10.1038/cdd.2009.149

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  19 in total

1.  Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase/Extracellular Signal-regulated Kinase (RAGE/Raf/MEK/ERK) Pathway.

Authors:  Hong-Zheng Meng; Wei-Lin Zhang; Fei Liu; Mao-Wei Yang
Journal:  J Biol Chem       Date:  2015-10-15       Impact factor: 5.157

2.  Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma.

Authors:  Brian A Boone; Nathan Bahary; Amer H Zureikat; A James Moser; Daniel P Normolle; Wen-Chi Wu; Aatur D Singhi; Phillip Bao; David L Bartlett; Lance A Liotta; Virginia Espina; Patricia Loughran; Michael T Lotze; Herbert J Zeh
Journal:  Ann Surg Oncol       Date:  2015-04-24       Impact factor: 5.344

3.  The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury.

Authors:  Rui Kang; Daolin Tang; Kristen M Livesey; Nicole E Schapiro; Michael T Lotze; Herbert J Zeh
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

4.  The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia.

Authors:  Rui Kang; Tara Loux; Daolin Tang; Nicole E Schapiro; Philip Vernon; Kristen M Livesey; Alyssa Krasinskas; Michael T Lotze; Herbert J Zeh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

Review 5.  The Beclin 1 network regulates autophagy and apoptosis.

Authors:  R Kang; H J Zeh; M T Lotze; D Tang
Journal:  Cell Death Differ       Date:  2011-02-11       Impact factor: 15.828

Review 6.  Oxidative stress and β-amyloid protein in Alzheimer's disease.

Authors:  Zhiyou Cai; Bin Zhao; Anna Ratka
Journal:  Neuromolecular Med       Date:  2011-09-08       Impact factor: 3.843

Review 7.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

8.  Autophagy in pancreatic cancer pathogenesis and treatment.

Authors:  Rui Kang; Daolin Tang
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

9.  Beclin-1 Deficiency Alters Autophagosome Formation, Lysosome Biogenesis and Enhances Neuronal Vulnerability of HT22 Hippocampal Cells.

Authors:  J Fekadu; A Rami
Journal:  Mol Neurobiol       Date:  2015-10-12       Impact factor: 5.590

10.  The marine natural product Scalarin inhibits the receptor for advanced glycation end products (RAGE) and autophagy in the PANC-1 and MIA PaCa-2 pancreatic cancer cell lines.

Authors:  Esther Amalia Guzmán; Tara Peterson Pitts; Maria Cristina Diaz; Amy Elizabeth Wright
Journal:  Invest New Drugs       Date:  2018-07-12       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.